Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1. [PDF]
Izzo M+18 more
europepmc +1 more source
Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1. [PDF]
Timchenko L.
europepmc +1 more source
Amphiphilic Oligonucleotide Derivatives-Promising Tools for Therapeutics. [PDF]
Bauer IA, Dmitrienko EV.
europepmc +1 more source
Association of Sjögren's syndrome with myotonic dystrophy type 1. [PDF]
Kitsis EA+3 more
europepmc +1 more source
Analysis of the DMPK gene CTG repeat in healthy Brazilians [PDF]
Ashizawa T+17 more
core +1 more source
A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism. [PDF]
Choi JH, Lee JY, Kim HJ, Jeon B.
europepmc +1 more source
Is Cardiac Transplantation Still a Contraindication in Patients with Muscular Dystrophy-Related End-Stage Dilated Cardiomyopathy? A Systematic Review. [PDF]
Politano L.
europepmc +1 more source
The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy [PDF]
キムラ, タカシ, 木村, 卓
core
Expanded CTG repeats in myotonin protein kinase increase susceptibility to oxidative stress
The effect of oxidative stress on myogenic cells with expanded CTG repeats in the myotonin protein kinase (MtPK) gene was investigated using MtPK cDNA-transformants in order to investigate the disease process underlying myotonic dystrophy. We employed methylmercury as a model for reagents that produce reactive oxygen species (ROS).
Shoichi Ishiura, Fusako Usuki
openaire +4 more sources